Pemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review)

Author：

E-ISSN： 1791-2423|48|1|13-27

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.48, Iss.1, 2016-01, pp. : 13-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Pemetrexed in Non-Small Cell Lung Cancer

By Longo-Sorbello Giuseppe Chen Bobin Budak-Alpdogan Tulin Bertino Joseph

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 59-66

Informa Healthcare

Access to resources Recommend Favorite

Clinical observation of pemetrexed on advanced non-small-cell lung cancer

By Zheng Yongfa Ge Wei Zhang Ling Zhao Zhenyu Jie Fangfang

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 140-143

Springer Publishing Company

Access to resources Recommend Favorite

The place of pemetrexed in the management of non-small-cell lung cancer patients

By Tomasini Pascale Greillier Laurent Khobta Nataliya Barlesi Fabrice

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed in heavily pretreated non-small-cell lung cancer patients: case report and review of the literature

By Tartarone Alfredo

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1937-1940

Future Medicine

Access to resources Recommend Favorite

The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis

By Qian Qian Wang Qian Zhan Ping Peng Ling Wei Shu-Zhen Shi Yi Song Yong

Cancer Investigation, Vol. 28, Iss. 6, 2010-06 ,pp. : 661-669

Informa Healthcare

Access to resources Recommend Favorite